Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia, B-Cell × Lansoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Zollinger-Ellison Syndrome 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Ulcer 1 Stomach Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia 1 Leukemia, B-Cell 1 Helicobacter Infections 1 Gastritis, Atrophic 1 Esophagitis, Peptic 1 Endometrial Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1 Breast Neoplasms 1 Barrett Esophagus 1

Interventions

ofatumumab 10 Rituximab 6 ibrutinib 5 Cyclophosphamide 5 fludarabine phosphate 4 Bendamustine Hydrochloride 4 fludarabine 3 Lenalidomide 3 Alemtuzumab 3 spebrutinib 2 navitoclax 2 acalabrutinib 2 KW-2478 2 venetoclax 1 tirabrutinib 1 obinutuzumab 1 idelalisib 1 dinaciclib 1 Tablets 1 Stem Cell Transplantation 1 Rabeprazole 1 Pentostatin 1 Metronidazole 1 Methylprednisolone 1 Magnetic Resonance Imaging 1 Leukapheresis 1 Lansoprazole 1 Itraconazole 1 Immunotherapy, Adoptive 1 Hsp90 inhibitor KU757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01279252 2019-01-25

CLEAR

King's College Hospital NHS Trust

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡